US$ 29.19
sublingual delivery glp-1 receptor agonists Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide 1 Agonists: A Scoping Review GLP-1 Agonists For Obesity In
Description
doi: 10.3390/cancers13040866

Antagonistic (one drug reduces the effect of another)

Finally, the GLP-1 effects on insulin secretion are dependent on the metabolic state of the individual

doi: 10.1056/NEJMoa2407379 21 AronneLJHornDBle RouxCWHoWFalconBLValderasEGet al

Conclusively, with regard to patients with pancreatic cancer and diabetes, GLP-1RAs have the potential to treat pancreatic cancer while also controlling the levels of blood glucose (210, 224)
Its ability to increase energy expenditure has been known for over 60 years (125)
